Incident and prevalent cohorts with pulmonary arterial hypertension: insight from SERAPHIN

Simonneau Gérald, Channick Richard N., Delcroix Marion, Galiè Nazzareno, Ghofrani Hossein-Ardeschir, Jansa Pavel, Le Brun Franck-Olivier, Mehta Sanjay, Perchenet Loic, Pulido Tomás, Sastry B.K.S., Sitbon Olivier, Souza Rogério, Torbicki Adam, Rubin Lewis J.

Source: Eur Respir J 2015; 46: 1711-1720
Journal Issue: December
Disease area: Pulmonary vascular diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Simonneau Gérald, Channick Richard N., Delcroix Marion, Galiè Nazzareno, Ghofrani Hossein-Ardeschir, Jansa Pavel, Le Brun Franck-Olivier, Mehta Sanjay, Perchenet Loic, Pulido Tomás, Sastry B.K.S., Sitbon Olivier, Souza Rogério, Torbicki Adam, Rubin Lewis J.. Incident and prevalent cohorts with pulmonary arterial hypertension: insight from SERAPHIN. Eur Respir J 2015; 46: 1711-1720

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension
Source: Eur Respir J 2010; 36: 549-555
Year: 2010



REVEAL: a contemporary US pulmonary arterial hypertension registry
Source: Eur Respir Rev 2012; 21: 8-18
Year: 2012


Survival in pulmonary hypertension in Spain: insights from the Spanish registry},
Source: Eur Respir J 2012; 40: 596-603
Year: 2012



The French registry of pulmonary arterial hypertension in children: characteristics at diagnosis
Source: Annual Congress 2007 - Clinical aspects of pulmonary arterial hypertension
Year: 2007



Risk assessment in pulmonary arterial hypertension (PAH): Insights from the GRIPHON study
Source: International Congress 2018 – Risk stratification in treatment of pulmonary arterial hypertension
Year: 2018




Hospitalization in patients with pulmonary arterial hypertension: causes and outcomes
Source: Annual Congress 2009 - Pulmonary circulation I
Year: 2009


Childhood pulmonary arterial hypertension: Insights from REVEAL
Source: Annual Congress 2011 - Clinical features of pulmonary hypertension
Year: 2011


An epidemiological study of pulmonary arterial hypertension
Source: Eur Respir J 2007; 30: 104-109
Year: 2007



Pulmonary arterial hypertension patients underrepresented in clinical trials – Are they different?
Source: International Congress 2016 – Pulmonary hypertension: the clinic II
Year: 2016

Riociguat for the treatment of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: Real-life data from the EXPERT registry
Source: International Congress 2015 – Pulmonary hypertension: new treatment insights
Year: 2015



Critical care outcomes in patients with pre-existing pulmonary hypertension: insights from the ASPIRE registry
Source: ERJ Open Res, 7 (2) 00046-2021; 10.1183/23120541.00046-2021
Year: 2021



Critical care outcomes in patients with pre-existing pulmonary hypertension: insights from the ASPIRE registry
Source: Virtual Congress 2021 – Therapy of pulmonary hypertension
Year: 2021


Variation in mortality from pulmonary hypertension by aetiology
Source: International Congress 2015 – Pulmonary hypertension: management
Year: 2015


Risk assessment in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
Source: Eur Respir J, 53 (6) 1802004; 10.1183/13993003.02004-2018
Year: 2019



Risk assessment in pulmonary arterial hypertension
Source: Eur Respir J, 51 (3) 1800279; 10.1183/13993003.00279-2018
Year: 2018



Risk assessment in pulmonary arterial hypertension
Source: Eur Respir Rev 2016; 25: 390-398
Year: 2016



Risk assessment in pulmonary arterial hypertension
Source: Eur Respir J, 51 (3) 1702606; 10.1183/13993003.02606-2017
Year: 2018



Pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: pathophysiology
Source: Eur Respir Rev 2009; 19: 59-63
Year: 2010



Relationship between comorbidities and quality of life perceived by patients diagnosed with pulmonary hypertension: Pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH)
Source: International Congress 2019 – Haemodynamics and chronic thromboembolic pulmonary hypertension
Year: 2019

Comparison of prevalence of diabetes mellitus in patients with idiopathic pulmonary arterial hypertension and distal chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2013 –Pulmonary circulation: chronic thromboembolic pulmonary hypertension, imaging and biomarkers
Year: 2013